Elizabeth H. and James S. McDonnell III Genome Institute
World leader in the fast-paced, constantly changing field of genomics
To unveil the secrets of the genome,
the blueprint of life,
to improve the lives of people everywhere
GTAC@MGI provides cutting-edge, cost-effective sequencing, and analysis technologies to collaborators. We are committed to generating the highest quality data and providing excellent value-added services and resources.
Genome Editing and
GEiC@MGI facilitates collaborators and customers with functional genomic studies through the use of patient-derived iPSCs and the generation of modified cells and organisms using genome editing technologies.
Since its inception in 1993, the McDonnell Genome Institute has played a vital role in the field of genome sequencing, receiving over $1.3 billion in research funding. Today, MGI has taken the COVID-19 Pandemic head on by developing a saliva based test to help detect who has contracted the illness